Abstract:Objective: To analyze the de novo point mutations in known genes among patients with unexplained intellectual disability (ID) or developmental retardation (DD). Methods: A total of 120 outpatients with ID or DD were recruited in the Department of Neurology, Affiliated Children's Hospital of Capital Institute of Pediatrics between September 2015 and April 2017. Target gene sequencing was used to screen the candidate gene. The sequencing data were analyzed by a variety of bioinformatics software. Combining with the phenotypes of the patients, the candidate genetic/genomic variants were identified from next-generation sequencing data. The final pathogenicity of the genetic/genomic variants were interpreted according to the guideline of the American College of Medical Genetics and Genomics (ACMG) for variants after segregation analysis in the parents and necessary family members by Sanger sequencing. The comprehensive physiological function and signaling pathways of 20 disease genes with de novo point mutation discovery was also studied. Results: Among the 120 patients, 23 patients were found to carry clear pathological changes, and the incidence of de novo point variation was 19.2%. The patients included 12 males and 11 females, with an age of 2 months to 6-year-6-month. Five patients were diagnosed with early onset of epileptic encephalopathy. Seven had mental retardation type 5, 6, 8, 19, 20, 22, 39, respectively. Weill-Marchesani syndrome type 2 was found in one case, Wiedemann-Steiner syndrome in one case, Coffin-Siris syndrome in two cases, Rubinstein-Taybi syndrome in one case, GLUT1 deficiency syndrome in one case, Rett syndrome in one case, cardio-facio-cutaneous syndrome 3 in one case, neurodegeneration with brain iron accumulation in one case, corpus callosum local dysplasia in one case, and congenital fibrosis of the extra-ocular muscles in one case. A total of 20 novel mutations were reported in this study. No somatic mutation was found in the samples of 6 patients with mutation and their parents' peripheral blood DNA samples by amplicon-based deep sequencing. This study found that the main disease genes were involved in chromatin remodeling, transcriptional regulation, autophagy body assembly, MAPK signal pathway, DNA methylation, potassium, sodium ion transport, cell skeleton assembly and skeletal muscle development. These genes were significantly enriched in the following biological processes: Ras signaling pathways, transcription factor binding and cancer related signaling pathway. Conclusions: The etiology of children affected with intellectual disability or developmental delay is complex. Harmful de novo point mutation plays an important role in these diseases. Targeted exome/genome sequencing based on the core family is helpful for the molecular diagnosis of patients and the discovery of more genes.

Identification and functional characterization of de novo variant in the SYNGAP1 gene causing intellectual disability

[Identification of a novel SYNGAP1 mutation in a child with intellectual disability].

Whole‐exome Sequencing Identified Five Novel De Novo Variants in Patients with Unexplained Intellectual Disability

Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

A case with autosomal dominant mental retardation type 5 due to de novo SYNGAP1 variant

[Study of de novo point mutations in known genes among patients with unexplained intellectual disability or developmental delay]

Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects

[Correlation of early neurodevelopmental features of children with SYNGAP1 variants and their genotypes]

A novel heterozygous ZBTB18 missense mutation in a family with non-syndromic intellectual disability and structural brain abnormalities

High Proportion of 22q13 Deletions and SHANK3 Mutations in Chinese Patients with Intellectual Disability.

Familial SYN1 Pathogenic Mutations Related Neurodevelopmental Disorders in Asian Pediatric Patients

Clinical and Genetic Analysis of Idiopathic Intellectual Disability/development Delay

A Novel Mutation in a Common Pathogenic Gene (SETD5) Associated with Intellectual Disability: A Case Report.

Novel SETBP1 Mutation in a Chinese Family with Intellectual Disability

Novel PAK3 Gene Missense Variant Associated with Two Chinese Siblings with Intellectual Disability: a Case Report

The Exploration of Genetic Aetiology and Diagnostic Strategy for 321 Chinese Individuals with Intellectual Disability

Novel variants in the CLCN4 gene associated with syndromic X-linked intellectual disability

De novo variants of DEAF1 cause intellectual disability in six Chinese patients

Novel GATAD2B loss-of-function mutations cause intellectual disability in two unrelated cases